Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karla B Neves

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
British Journal of Pharmacology|February 16, 2026
Renal-vascular axis: unmasking its role in vascular endothelial growth factor-inhibitor vascular toxicity in cancer patientsGrace Whelan, Karla B Neves
The Canadian Journal of Cardiology|April 8, 2019
Muscarinic Receptor Type-3 in Hypertension and Cholinergic-Adrenergic Crosstalk: Genetic Insights and Potential for New Antihypertensive TargetsRhéure Alves-Lopes, Karla B Neves, Rhian M Touyz
Methods in Molecular Biology (Clifton, N.J.)|January 25, 2017
Isolation and Culture of Endothelial Cells from Large VesselsAugusto C Montezano, Karla B Neves, Rheure A M Lopes, et al.
Clinical Science (London, England : 1979)|September 29, 2020
Vascular toxicity associated with anti-angiogenic drugsKarla B Neves, Augusto C Montezano, Ninian N Lang, et al.
Journal of the American Heart Association|February 21, 2023
Role of PARP and TRPM2 in VEGF Inhibitor-Induced Vascular DysfunctionKarla B Neves, Rheure Alves-Lopes, Augusto C Montezano, et al.
Frontiers in Physiology|April 6, 2018
Perivascular Adipose Tissue as a Relevant Fat Depot for Cardiovascular Risk in ObesityRafael M Costa, Karla B Neves, Rita C Tostes, et al.
Experimental Physiology|June 17, 2026
VEGF inhibitor-induced vascular dysfunction involves redox-sensitive PARP activation and SIRT1 disruptionKarla B Neves, Rheure Alves-Lopes, Augusto C Montezano, et al.
Frontiers in Physiology|April 20, 2012
Testosterone and vascular function in agingRhéure A M Lopes, Karla B Neves, Fernando S Carneiro, et al.
JACC. Cardiooncology|August 16, 2021
Reply: Cisplatin-Associated Aortic Thrombosis: A Review of Cases Reported to the FDA Adverse Event Reporting SystemAlan C Cameron, Karla B Neves, Jeff White, et al.
Clinical Science (London, England : 1979)|December 24, 2019
Notch3 signalling and vascular remodelling in pulmonary arterial hypertensionHannah E Morris, Karla B Neves, Augusto C Montezano, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
British Journal of Pharmacology|February 16, 2026
Renal-vascular axis: unmasking its role in vascular endothelial growth factor-inhibitor vascular toxicity in cancer patientsGrace Whelan, Karla B Neves
The Canadian Journal of Cardiology|April 8, 2019
Muscarinic Receptor Type-3 in Hypertension and Cholinergic-Adrenergic Crosstalk: Genetic Insights and Potential for New Antihypertensive TargetsRhéure Alves-Lopes, Karla B Neves, Rhian M Touyz
Methods in Molecular Biology (Clifton, N.J.)|January 25, 2017
Isolation and Culture of Endothelial Cells from Large VesselsAugusto C Montezano, Karla B Neves, Rheure A M Lopes, et al.
Clinical Science (London, England : 1979)|September 29, 2020
Vascular toxicity associated with anti-angiogenic drugsKarla B Neves, Augusto C Montezano, Ninian N Lang, et al.
Journal of the American Heart Association|February 21, 2023
Role of PARP and TRPM2 in VEGF Inhibitor-Induced Vascular DysfunctionKarla B Neves, Rheure Alves-Lopes, Augusto C Montezano, et al.
Frontiers in Physiology|April 6, 2018
Perivascular Adipose Tissue as a Relevant Fat Depot for Cardiovascular Risk in ObesityRafael M Costa, Karla B Neves, Rita C Tostes, et al.
Experimental Physiology|June 17, 2026
VEGF inhibitor-induced vascular dysfunction involves redox-sensitive PARP activation and SIRT1 disruptionKarla B Neves, Rheure Alves-Lopes, Augusto C Montezano, et al.
Frontiers in Physiology|April 20, 2012
Testosterone and vascular function in agingRhéure A M Lopes, Karla B Neves, Fernando S Carneiro, et al.
JACC. Cardiooncology|August 16, 2021
Reply: Cisplatin-Associated Aortic Thrombosis: A Review of Cases Reported to the FDA Adverse Event Reporting SystemAlan C Cameron, Karla B Neves, Jeff White, et al.
Clinical Science (London, England : 1979)|December 24, 2019
Notch3 signalling and vascular remodelling in pulmonary arterial hypertensionHannah E Morris, Karla B Neves, Augusto C Montezano, et al.
Pageof 5